"In a pilot trial involving 16 women with preterm preeclampsia, researchers found that filtering out a protein called sFlt-1 from the pregnant women's blood was both safe and could modestly reduce their blood pressure."
"We're excited about this. [It's the] first time anyone has developed a targeted treatment for this condition, says Ravi Thadhani, the study's lead author and executive vice president of clinical affairs and chief medical officer at the Cedars-Sinai Medical Center and Cedars-Sinai Health System."
Preeclampsia is a serious pregnancy condition characterized by high blood pressure and protein in urine, affecting about one in twelve pregnancies in the U.S. Currently, the only cure is delivery, which can lead to complications. Preliminary research suggests that filtering the protein sFlt-1 from the blood of women with preterm preeclampsia may safely lower blood pressure. This pilot trial involved 16 women and indicates a potential new treatment avenue, although further research is necessary to confirm these findings.
Read at www.scientificamerican.com
Unable to calculate read time
Collection
[
|
...
]